Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation.
| Autor: | Gonzalez-Rodriguez, Elena1,2, Stoll, Delphine1, Lamy, Olivier1,3 |
|---|---|
| Zdroj: | Case Reports in Rheumatology. 9/17/2018, p1-4. 4p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|